loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Phenylalanine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Phenylalanine

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 104Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jnana Presents JNT-517 Data, Plans 2025 Pivotal Study
    Jnana Presents JNT-517 Data, Plans 2025 Pivotal Study

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940409/0/en/Jnana-Therapeutics-Presents-New-Positive-Data-from-Phase-1-2-Study-of-JNT-517-in-Individuals-with-Phenylketonuria-Results-Support-Planned-Pivotal-Study-in-Early-2025.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Relief Announces U.S. Launch of PKU GOLIKE
    Relief Announces U.S. Launch of PKU GOLIKE

    10 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/719588/Relief-Announces-US-Launch-of-PKU-GOLIKE

    ACCESSWIRE
    10 Oct 2022
    Share Share
    Synlogic Announces Positive Phase 2 Data for SYNB1618
    Synlogic Announces Positive Phase 2 Data for SYNB1618

    20 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/synlogic-announces-positive-phase-2-data-demonstrating-reduction-in-plasma-phenylalanine-levels-in-patients-with-phenylketonuria-301380078.html

    PRNEWSWIRE
    20 Sep 2021
    Share Share
    Jnana nets $50M to push newly unveiled PKU program
    Jnana nets $50M to push newly unveiled PKU program

    19 Aug 2021

    // A. Al Idrus FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/jnana-nets-50m-to-push-newly-unveiled-pku-program-expand-into-more-hard-to-drug-targets

    A. Al Idrus FIERCEBIOTECH
    19 Aug 2021
    Share Share
    BioMarin begins patient dosing in phI/II study of BMN 307
    BioMarin begins patient dosing in phI/II study of BMN 307

    25 Sep 2020

    // S. Rafael PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131397&sid=2

    S. Rafael PHARMABIZ
    25 Sep 2020
    Share Share
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines
    European Medicines Agency (EMA) publishes information on excipients for labeling & package leaflet of human medicines

    01 Jan 2019

    // EMA

    https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/reference-guidelines/excipients-labelling

    EMA
    01 Jan 2019
    Share Share